✨ Education and Health Notices




6 JUNE

NEW ZEALAND GAZETTE

The said supplementary integration agreement was executed on 28 May 2002.
A copy of the supplementary integration agreement is available for inspection without charge by any member of the public at the regional office of the Ministry of Education, corner of Grey and Bridge Streets, Hamilton.
Dated at Wellington this 28th day of May 2002.

KATHY PHILLIPS, Senior Manager, National Operations.

go3651

Supplementary Integration Agreement

Pursuant to section 10 of the Private Schools Conditional Integration Act 1975, notice is given that a supplementary integration agreement has been signed between the Minister of Education on behalf of Her Majesty the Queen, acting through the Senior Manager, National Operations, Ministry of Education, pursuant to delegated authority, and the proprietor of the following school:

Hukarere School, Napier.

The said supplementary integration agreement was executed on 29 May 2002.
A copy of the supplementary integration agreement is available for inspection without charge by any member of the public at the regional office of the Ministry of Education, 65 Waterloo Road, Lower Hutt.
Dated at Wellington this 29th day of May 2002.

KATHY PHILLIPS, Senior Manager, National Operations.

go3758

1559

Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Acihexal 5%

Active Ingredient:
Aciclovir 5%w/w

Dosage Form:
Topical cream

New Zealand Sponsor:
Hexal New Zealand Pty Limited

Manufacturer:
Soul Pattinson Manufacturing Pty Limited, Kingsgrove, New South Wales, Australia

Product:
Actos

Active Ingredient:
Pioglitazone hydrochloride 16.53mg equivalent to 15mg pioglitazone

Dosage Form:
Tablet

New Zealand Sponsor:
Eli Lilly and Company (NZ) Limited

Manufacturers:
Takeda Chemical Industries Limited, Yodogawa-ku, Osaka, Japan
Takeda Ireland Limited, Kilruddery, County Wicklow, Ireland

Product:
Actos

Active Ingredient:
Pioglitazone hydrochloride 33.06mg equivalent to 30mg pioglitazone

Dosage Form:
Tablet

New Zealand Sponsor:
Eli Lilly and Company (NZ) Limited

Manufacturers:
Takeda Chemical Industries Limited, Yodogawa-ku, Osaka, Japan
Takeda Ireland Limited, Kilruddery, County Wicklow, Ireland

Product:
Actos

Active Ingredient:
Pioglitazone hydrochloride 49.59mg equivalent to 45mg pioglitazone

Dosage Form:
Tablet

New Zealand Sponsor:
Eli Lilly and Company (NZ) Limited

Manufacturers:
Takeda Chemical Industries Limited, Yodogawa-ku, Osaka, Japan
Takeda Ireland Limited, Kilruddery, County Wicklow, Ireland

Product:
Elidel

Active Ingredient:
Pimecrolimus 10mg

Dosage Form:
Topical cream

New Zealand Sponsor:
Novartis New Zealand Limited

Manufacturer:
Novartis Pharma GmbH, Wehr, Germany

Dated this 29th day of May 2002.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go3719



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2002, No 58


Gazette.govt.nz PDF NZ Gazette 2002, No 58





✨ LLM interpretation of page content

πŸŽ“ Supplementary Integration Agreement for Sacred Heart Girls’ College (continued from previous page)

πŸŽ“ Education, Culture & Science
28 May 2002
Private Schools, Integration, Hamilton
  • KATHY PHILLIPS, Senior Manager, National Operations

πŸŽ“ Supplementary Integration Agreement for Hukarere School

πŸŽ“ Education, Culture & Science
29 May 2002
Private Schools, Integration, Napier
  • KATHY PHILLIPS, Senior Manager, National Operations

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
29 May 2002
Medicines, Distribution, Consent, New Zealand
  • G. R. BOYD, Chief Advisor, Safety and Regulation